IRCT20140818018842N40
Recruiting
Phase 1
Evaluaing the safety and effectiveness of intravenous infusion of placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cell exosomes in steroid-resistant acute GvHD patients; Phase I and II clinical trial
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Acute GvHD.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acute aGvHD grade II\-IV according to MAGIC criteria and steroid resistant according to EBMT\-NIH\-CIBMTR
- •A patient who underwent allogeneic HSCT with the following conditions: HLA\-matched donor (MRD), HLA\-mismatched donor (MUD), unrelated cord blood (UCB), haploidal donor
Exclusion Criteria
- •Positive serology for hepatitis B, hepatitis C and AIDS virus or fungal infection
- •Patients with penicillin and/or gentamicin allergy or known allergy to cow or pork products
- •Participants with uncontrolled diseases including persistent or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness or specific social situations that limit compliance with study requirements
- •Any condition that, in the investigator's judgment, interferes with full participation in the study, including the administration of study medication or participation in required study visits, or poses a significant risk to the participant, or interferes with the interpretation of study data
- •Transplant recipient for solid tumor
- •Diagnosis of Sinus Obstructive Syndrome (SOS) or Venous Obstructive Disease, at any time of study with appropriate tests
- •Pregnancy and breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Vaccination against prostate cancerISRCTN14654848Ahvaz Jundishapur University of Medical Sciences30
Completed
N/A
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
Completed
N/A
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
Active, Not Recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10
Recruiting
Phase 1
Safety and efficacy evaluation of using natural killer cells to treat patients with recurrent and refractory high-risk neuroblastomaIRCT20170122032121N8Kian immune cell company10